SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-044327
Filing Date
2021-08-13
Accepted
2021-08-13 16:31:23
Documents
65
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q abcl-10q_20210630.htm   iXBRL 10-Q 3155842
2 EX-31.1 abcl-ex311_6.htm EX-31.1 20972
3 EX-31.2 abcl-ex312_9.htm EX-31.2 20938
4 EX-32.1 abcl-ex321_7.htm EX-32.1 9461
5 EX-32.2 abcl-ex322_8.htm EX-32.2 9438
6 GRAPHIC gthwch2nyifg000001.jpg GRAPHIC 98479
  Complete submission text file 0001564590-21-044327.txt   8282814

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA abcl-20210630.xsd EX-101.SCH 41628
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abcl-20210630_cal.xml EX-101.CAL 58061
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abcl-20210630_def.xml EX-101.DEF 141408
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE abcl-20210630_lab.xml EX-101.LAB 357579
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abcl-20210630_pre.xml EX-101.PRE 267246
12 EXTRACTED XBRL INSTANCE DOCUMENT abcl-10q_20210630_htm.xml XML 1196111
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39781 | Film No.: 211172663
SIC: 2834 Pharmaceutical Preparations